CORRECTION article

Front. Oncol., 07 September 2021

Sec. Gynecological Oncology

Volume 11 - 2021 | https://doi.org/10.3389/fonc.2021.742374

Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway

  • 1. Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, China

  • 2. Key Laboratory of Gynecology Oncology of Shandong Province, Qilu Hospital of Shandong University, Jinan, China

  • 3. Shandong Engineering Laboratory for Urogynecology, Qilu Hospital of Shandong University, Jinan, China

  • 4. Department of Gynecology and Obstetrics, Affiliated Tengzhou Center People’s Hospital of Jining Medical University, Tengzhou, China

In the original article, there was a mistake in Figure 5B as published. We recognized by ourself that the picture of “PI3K” was the same as that of “pan-AKT”, we made a mistake when we dragged the original figure into the AI software.

The corrected Figure 5B appears below.

Figure 5

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

ACLY, ovarian cancer, cisplatin resistance, PI3K-AKT pathway, AMPK-ROS pathway

Citation

Wei X, Shi J, Lin Q, Ma X, Pang Y, Mao H, Li R, Lu W, Wang Y and Liu P (2021) Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway. Front. Oncol. 11:742374. doi: 10.3389/fonc.2021.742374

Received

16 July 2021

Accepted

20 August 2021

Published

07 September 2021

Volume

11 - 2021

Edited and reviewed by

Haifeng Qiu, Zhengzhou University, China

Updates

Copyright

*Correspondence: Peishu Liu, ; Yu Wang,

This article was submitted to Gynecological Oncology, a section of the journal Frontiers in Oncology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics